GCcell Appoints Joonhee Son as Head of Business Development

Experience in BD and Investment Strategy at Dong-A Socio and Lotte Biologics

GCcell announced on August 10 that it has appointed Joonhee Son as Head of Business Development to strengthen its business development (BD) capabilities.

Joonhee Son, Head of Business Development at GC Cell. GC Cell

Son graduated from the College of Veterinary Medicine at Chungbuk National University and earned a master's degree in internal medicine from the same university's College of Medicine. Son has worked at Dong-A Pharmaceutical, Dong-A Socio Holdings, and Dong-A ST, where she was responsible for R&D strategy, business development, investment review, and portfolio management.

Most recently, she served as Head of the Investment Strategy Team in Lotte Group's Management Innovation Office and as Head of the BD Strategy Team in the Global BD division at Lotte Biologics, where she oversaw bio investment strategy, global business development, sales strategy, and partnership management.

A GCcell representative stated, "We expect that Son will play a vital role in significantly strengthening our business development capabilities, expanding global partnerships, and identifying new business opportunities to establish a foundation for long-term growth."

This content was produced with the assistance of AI translation services.